Back to School: How biopharma can reboot drug development. Access exclusive analysis here
NLA cetirizine is in Phase II testing to treat allergic and non-allergic rhinitis. BLX-CLI is a preclinical program for
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury